+ Site Statistics
References:
52,572,879
Abstracts:
28,705,754
PMIDs:
27,750,366
DOIs:
25,464,004
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

COOH-terminal fragments of cholecystokinin. A new class of cholecystokinin receptor antagonists



COOH-terminal fragments of cholecystokinin. A new class of cholecystokinin receptor antagonists



Biochimica et Biophysica Acta 757(2): 250-258



COOH-terminal fragments of cholecystokinin varying in length from 1 to 3 amino acids and their NH2-terminal butyloxycarbonyl derivatives were investigated for their ability to interact with the cholecystokinin receptor on dispersed acini from guinea pig pancreas. No fragment stimulated amylase secretion when present alone, but each of the butyloxycarbonyl derivatives and the COOH-terminal tripeptide amide inhibited the stimulation of enzyme secretion by cholecystokinin. In each case the inhibition was surmounted by increasing the concentration of cholecystokinin. Each fragment also inhibited binding of 125I-labeled cholecystokinin, with significant inhibition occurring with 30 microM butyloxycarbonyl tripeptide amide, 0.3 mM butyloxycarbonyl dipeptide amide, 10 mM butyloxycarbonyl phenylalanine amide and 3 mM tripeptide amide of cholecystokinin. In each case, there was a close correlation between the ability of the fragment to inhibit binding of 125I-labeled cholecystokinin and its ability to inhibit cholecystokinin-stimulated amylase release, cholecystokinin-stimulated 45Ca outflux and cholecystokinin-stimulated residual stimulation of amylase secretion. The inhibition of amylase secretion caused by the butyloxycarbonyl tripeptide of cholecystokinin was reversible and specific for those peptides which interact with the cholecystokinin receptor (i.e., cholecystokinin, caerulein, gastrin); it did not inhibit the actions of bombesin, carbachol, physalaemin, vasoactive intestinal peptide, secretin, PHI, ionophore A23187 or 8-bromo cyclic AMP. These results demonstrate that COOH-terminal fragments of cholecystokinin comprise a new class of cholecystokinin receptor antagonists.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 042429010

Download citation: RISBibTeXText

PMID: 6189522

DOI: 10.1016/0304-4165(83)90115-0


Related references

Amino terminal fragments of cholecystokinin 26 33 as cholecystokinin receptor antagonists in guinea pig pancreatic acini. American Journal of Physiology 248(1 PART 1): G98-G102, 1985

Cholecystokinin-27-32-amide. A member of a new class of cholecystokinin receptor antagonists. Journal of Biological Chemistry 258(11): 6746-6749, 1983

N-terminal fragments of CCK-(26-33) as cholecystokinin receptor antagonists in guinea pig pancreatic acini. American Journal of Physiology 248(1 Pt 1): G98-102, 1985

Conformational analysis of cholecystokinin fragments cholecystokinin 4 cholecystokinin 5 and cholecystokinin 6 proton nmr spectroscopy and fluorescence transfer measurements. Biopolymers 24(9): 1663-1682, 1985

The effect of cholecystokinin (CCK-33) and C-terminal fragments of cholecystokinin: CCK-8 and CCK-4 on the cardiovascular system in rats. General Pharmacology 27(1): 159-163, 1996

Irreversible photoactivation of a pancreatic secretagogue receptor with cholecystokinin COOH-terminal octapeptides. Journal of Biological Chemistry 255(7): 3148-3155, 1980

The effects of cholecystokinin and cholecystokinin receptor antagonists on proximal colonic motility in the anesthetized dog. Digestive Diseases & Sciences 29(8 SUPPL): 8S, 1984

Cyclic nucleotide antagonists of cholecystokinin: structural requirements for interaction with the cholecystokinin receptor. American Journal of Physiology 242(2): G161-G167, 1982

The effect of cholecystokinin-receptor antagonists on cholecystokinin-stimulated bile flow in dogs. Surgery 109(3 Pt 1): 294-300, 1991

Cholecystokinin receptor antagonists ability to distinguish various classes of cholecystokinin receptors. Thompson, J C (Ed ) Gastrointestinal Endocrinology: Receptors And Post-Receptor Mechanisms; Second Galveston International Symposium, Galveston, Texas, Usa, April 2-5, 1989 Xxvi+519p Academic Press, Inc : San Diego, California, Usa; London, England, Uk Illus 95-114, 1990

Derivatives of cholecystokinin 26 32 as cholecystokinin receptor antagonists in guinea pig pancreatic acini. American Journal of Physiology 246(3 PART 1): G292-G295, 1984

Effect of cholecystokinin receptor antagonists, MK-329 and L-365,260, on cholecystokinin-induced acid secretion and histidine decarboxylase activity in the rat. Regulatory Peptides 35(1): 1-10, 1991

Lack of competition between two reputed peripheral cholecystokinin receptor antagonists for central cholecystokinin binding sites. Annals of the New York Academy of Sciences 448(none): 581-582, 1985

Role of Cholecystokinin in the Development and Progression of Acute Pancreatitis and the Potential of Therapeutic Application of Cholecystokinin Receptor Antagonists. Digestion 60(Suppl. 1): 69-74, 1999

Role of cholecystokinin in the development and progression of acute pancreatitis and the potential of therapeutic application of cholecystokinin receptor antagonists. Digestion 60 Suppl 1: 69-74, 1999